MTF1
Basic information
Region (hg38): 1:37809574-37859592
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal dominant 40 (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 26 | 31 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 6 | 3 |
Variants in MTF1
This is a list of pathogenic ClinVar variants found in the MTF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-37815162-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
1-37815176-C-A | not specified | Uncertain significance (Jul 12, 2023) | ||
1-37815194-A-G | not specified | Uncertain significance (Jan 06, 2023) | ||
1-37815235-T-C | Likely benign (May 24, 2018) | |||
1-37815258-C-A | not specified | Uncertain significance (Sep 04, 2024) | ||
1-37815302-C-T | not specified | Uncertain significance (Apr 12, 2022) | ||
1-37815335-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
1-37815345-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
1-37815365-A-G | not specified | Uncertain significance (Dec 15, 2023) | ||
1-37815374-G-T | not specified | Uncertain significance (Dec 08, 2023) | ||
1-37815426-G-C | not specified | Uncertain significance (May 04, 2022) | ||
1-37815465-G-A | not specified | Uncertain significance (Aug 27, 2024) | ||
1-37822163-T-C | not specified | Uncertain significance (Jul 18, 2024) | ||
1-37822245-G-C | not specified | Uncertain significance (Feb 27, 2024) | ||
1-37822315-T-C | not specified | Uncertain significance (May 23, 2023) | ||
1-37822320-T-G | not specified | Uncertain significance (Oct 14, 2021) | ||
1-37822342-C-A | not specified | Uncertain significance (Jun 30, 2024) | ||
1-37822359-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
1-37822363-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
1-37822413-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
1-37822417-C-T | not specified | Uncertain significance (Aug 12, 2022) | ||
1-37822428-G-A | not specified | Uncertain significance (Feb 26, 2024) | ||
1-37822518-G-A | not specified | Uncertain significance (Apr 24, 2024) | ||
1-37822555-G-A | Likely benign (Dec 31, 2019) | |||
1-37822561-G-A | not specified | Uncertain significance (Oct 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MTF1 | protein_coding | protein_coding | ENST00000373036 | 10 | 50054 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.969 | 0.0310 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.54 | 272 | 418 | 0.650 | 0.0000219 | 4903 |
Missense in Polyphen | 61 | 149 | 0.40939 | 1748 | ||
Synonymous | 0.481 | 159 | 167 | 0.953 | 0.00000951 | 1547 |
Loss of Function | 4.50 | 5 | 32.8 | 0.152 | 0.00000190 | 350 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Activates the metallothionein I promoter. Binds to the metal responsive element (MRE). {ECO:0000269|PubMed:8065932}.;
- Pathway
- Copper homeostasis;Zinc homeostasis;MTF1 activates gene expression;Response to metal ions;Cellular responses to external stimuli
(Consensus)
Recessive Scores
- pRec
- 0.0966
Intolerance Scores
- loftool
- 0.211
- rvis_EVS
- 0.0000761
- rvis_percentile_EVS
- 53.98
Haploinsufficiency Scores
- pHI
- 0.886
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.458
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.578
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mtf1
- Phenotype
- vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; liver/biliary system phenotype; embryo phenotype; neoplasm; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;response to oxidative stress;central nervous system development;response to metal ion;positive regulation of transcription by RNA polymerase II;response to cadmium ion
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;proximal promoter sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription coactivator activity;protein binding;histone acetyltransferase binding;metal ion binding